Pharmaceuticals

Lundbeck is one of the most focused specialty pharmaceutical companies in brain disease, with long-standing activity in psychiatry, neurology, depression, schizophrenia, migraine, Parkinson’s disease, and other central nervous system conditions.

Lonza is one of the world’s leading CDMO providers and a benchmark institution in biomanufacturing. The company supports pharmaceutical and biotechnology sponsors across biologics, small molecules, cell and gene therapy, drug product services, microbial manufacturing, mammalian cell culture, and advanced therapeutic manufacturing.

Legend Biotech is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biotechnology Firms 2 ranking categories Overview

Kyverna Therapeutics is a specialist cell therapy developer focused on autoimmune disease. Its platform applies CAR-T technology to B-cell mediated autoimmune conditions, reflecting one of the most important expansion areas for cellular immunotherapy.

Krystal Biotech is an increasingly important rare disease developer focused on genetic skin diseases and gene therapy. Its approved product Vyjuvek treats dystrophic epidermolysis bullosa, a severe genetic skin disorder, and has given the company a commercial rare disease platform.

Kiniksa Pharmaceuticals is a specialist rare disease company focused on inflammatory and cardiovascular-related orphan conditions. Its flagship product, Arcalyst, is approved for recurrent pericarditis and cryopyrin-associated periodic syndromes, giving the company a focused commercial rare disease platform.

KCR is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Contract Research Organizations 1 ranking category Overview

KBI Biopharma is a biologics CDMO providing process development, analytical development, formulation, microbial manufacturing, mammalian cell culture, and clinical manufacturing services. The company serves biotechnology and pharmaceutical sponsors developing proteins, antibodies, and other biologics.

KalVista Pharmaceuticals is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Rare Disease & Orphan Drug Developers 1 ranking category Overview

Jazz Pharmaceuticals is a specialty pharmaceutical company focused on neuroscience, sleep medicine, oncology, and rare disease. The company’s commercial identity has been shaped by specialist-managed neurological and sleep disorders, as well as selected oncology products.

Ironwood Pharmaceuticals is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Specialty Pharma Companies 1 ranking category Overview

IQVIA is one of the most important Contract Research Organizations globally, combining large-scale clinical development services with healthcare data, analytics, real-world evidence, consulting, and technology platforms. Its position is distinctive because it operates not only as a CRO, but also as a healthcare information and analytics company serving pharmaceutical, biotechnology, payer, provider, and government clients.

Ipsen is a European specialty pharmaceutical company with strong focus in oncology, rare disease, and neuroscience. The company’s business model is clearly aligned with specialist physician markets and clinically differentiated therapies.

Ionis Pharmaceuticals is one of the most important RNA medicine companies in rare disease development. The company’s antisense oligonucleotide platform has contributed to approved medicines and partnerships across neurological, metabolic, cardiovascular, and rare genetic disease areas.

Intellia Therapeutics is a leading developer of in vivo CRISPR-based therapies. Unlike ex vivo approaches that modify cells outside the body, Intellia’s platform is focused on delivering gene editing components directly into patients, particularly for liver-expressed disease targets.

Inovio Pharmaceuticals is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Vaccine & Immunotherapy Developers 1 ranking category Overview

Incyte is an established specialty pharmaceutical company focused on oncology, hematology, inflammation, and dermatology. Its commercial foundation is built around specialist-managed disease areas, particularly hematologic malignancies and targeted therapies.

ICON plc is one of the world’s largest full-service CROs, with major capabilities across clinical trial management, site and patient services, data management, biostatistics, pharmacovigilance, regulatory affairs, decentralized trial support, and real-world evidence. Its acquisition of PRA Health Sciences significantly expanded its global scale and therapeutic coverage.

Harmony Biosciences is a specialist pharmaceutical company focused on rare neurological and sleep-wake disorders. Its core commercial activity has been associated with narcolepsy, a rare neurological disorder involving excessive daytime sleepiness and cataplexy.

Halozyme Therapeutics is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biotechnology Firms 1 ranking category Overview